Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Animals (4)
- Organisms (4)
- Research Methods in Life Sciences (4)
- Bioethics and Medical Ethics (3)
- Pharmacology, Toxicology and Environmental Health (3)
-
- Social and Behavioral Sciences (3)
- Animal Experimentation and Research (2)
- Animal Studies (2)
- Business (2)
- Physical Sciences and Mathematics (2)
- Toxicology (2)
- Anatomy (1)
- Chemicals and Drugs (1)
- Chemistry (1)
- Diseases (1)
- Endocrine System (1)
- Endocrine System Diseases (1)
- Environmental Health and Protection (1)
- Environmental Public Health (1)
- Environmental Sciences (1)
- European Law (1)
- International Business (1)
- Law (1)
- Legislation (1)
- Medical Sciences (1)
- Keyword
-
- OECD (2)
- REACH (2)
- AXLR8 (1)
- Adverse outcome pathway (1)
- Alternative methods (1)
-
- Animal testing (1)
- Chemical (1)
- Cosmetic (1)
- Data requirements (1)
- Dermal toxicity (1)
- Developmental toxicity (1)
- Endocrine disrupter testing (1)
- Generation study (1)
- HSI (1)
- Horizon 2020 (1)
- Human Toxicology Project (1)
- Immunotoxicity (1)
- Intelligent testing (1)
- LD50 (1)
- Neurotoxicity (1)
- Non-animal test methods (1)
- Pesticide (1)
- Prevalence (1)
- ReProTect (1)
- Redundancy (1)
- Regulatory alignment (1)
- Regulatory classification (1)
- Reproduction toxicity (1)
- Reproductive toxicity (1)
- Testing strategy (1)
Articles 1 - 5 of 5
Full-Text Articles in Veterinary Medicine
Examining The Regulatory Value Of Multi-Route Mammalian Acute Systemic Toxicity Studies, Troy Seidle, Pilar Prieto, Anna Bulgheroni
Examining The Regulatory Value Of Multi-Route Mammalian Acute Systemic Toxicity Studies, Troy Seidle, Pilar Prieto, Anna Bulgheroni
Troy Seidle, PhD
Regulatory information requirements for pesticides call for submission of acute systemic toxicity data for up to three different exposure routes (oral, dermal, inhalation) for both active ingredients and formulated products. Similar multi-route testing is required in the European Union and elsewhere for industrial chemicals. To determine the value of acute toxicity testing by more than one route, oral-dermal and oralinhalation concordances among regulatory classifications were examined for large data sets of chemicals and pesticide active ingredients. Across all sectors examined, oral acute toxicity classifications for pure active substances were more severe than those derived from dermal data in more than …
The Development Of New Concepts For Assessing Reproductive Toxicity Applicable To Large Scale Toxicological Programmes, S. Bremer, C. Pellizzer, S. Hoffmann, T. Seidle, T. Hartung
The Development Of New Concepts For Assessing Reproductive Toxicity Applicable To Large Scale Toxicological Programmes, S. Bremer, C. Pellizzer, S. Hoffmann, T. Seidle, T. Hartung
Troy Seidle, PhD
Large scale toxicological testing programmes which are currently ongoing such as the new European chemical legislation REACH require the development of new integrated testing strategies rather than applying traditional testing schemes to thousands of chemicals. The current practice of requiring in vivo testing for every possible adverse effect endanger the success of these programmes due (i) to limited testing facilities and sufficient capacity of scientific/technical knowledge for reproductive toxicity; (ii) an unacceptable number of laboratory animals involved (iii) an intolerable number of chemicals classified as false positive.
A key aspect of the implementation of new testing strategies is the determination …
A Modular One-Generation Reproduction Study As A Flexible Testing System For Regulatory Safety Assessment, Richard Vogel, Troy Seidle, Horst Spielmann
A Modular One-Generation Reproduction Study As A Flexible Testing System For Regulatory Safety Assessment, Richard Vogel, Troy Seidle, Horst Spielmann
Troy Seidle, PhD
The European Union’s Registration, Evaluation and Authorisation of Chemicals (REACH) legislation mandates testing and evaluation of approximately 30,000 existing substances within a short period of time, beginning with the most widely used “high production volume” (HPV) chemicals. REACH testing requirements for the roughly 3000 HPV chemicals specify three separate tests for reproductive toxicity: two developmental toxicity studies on different animal species (OECD Test Guideline 414) and a two-generation reproduction toxicity study (OECD TG 416). These studies are highly costly in both economic and animal welfare terms. OECD TG 416 is a fertility study intended to evaluate reproductive performance of animals …
Ideology Masquerading As Science: The Case Of Endocrine Disrupter Screening Programmes, Troy Seidle
Ideology Masquerading As Science: The Case Of Endocrine Disrupter Screening Programmes, Troy Seidle
Troy Seidle, PhD
The global move to develop novel testing methods and strategies to identify suspected endocrine disrupting chemicals offers a unique opportunity to move away from traditional animal testing paradigms in this new area of regulatory concern. Regrettably, the programmes under development, both in the USA and internationally through the OECD, have thus far failed to consider in vitro and other nonanimal test methods as more than “pre-screening” or “priority-setting” tools in a larger, animal-based testing strategy. Validation efforts to date have focused almost exclusively on the modification of existing animal tests to detect “endocrine effects”, with no demonstrable effort to promote …
Humane Society International’S Global Campaign To End Animal Testing, Troy Seidle
Humane Society International’S Global Campaign To End Animal Testing, Troy Seidle
Troy Seidle, PhD
The Research & Toxicology Department of Humane Society International (HSI) operates a multifaceted and science-driven global programme aimed at ending the use of animals in toxicity testing and research. The key strategic objectives include: a) ending cosmetics animal testing worldwide, via the multinational Be Cruelty-Free campaign; b) achieving near-term reductions in animal testing requirements through revision of product sector regulations; and c) advancing humane science by exposing failing animal models of human disease and shifting science funding toward human biology-based research and testing tools fit for the 21st century. HSI was instrumental in ensuring the implementation of the March 2013 …